Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, October 6, 2009 - Flublok


Submission Type: Original Application   Submission ID:  125285/0   Office: OVRR  
Influenza Vaccine
Protein Sciences Corporation          
Telecon Date/Time:  06-OCT-2009 02:15 PM              Initiated by FDA?  Yes
Telephone Number:  203-599-6064
Communication Categorie(s):
Information Request
Telecon Summary:
Dr. Penny Post was called to clarify some details of the September 24, 2009 face-to-face meeting with CBER.
FDA Participants:  
Timothy Fritz
Non-FDA Participants:   
Penny Post
Trans-BLA Group: No
Related STNs:  None
Related PMCs:  None
Telecon Body:
Dr. Post was phoned to ask for clarification regarding details of the September 24, 2009 face-to-face meeting between Protein Science Corporation (PSC) and FDA.
Dr. Post was asked if she cold provide:
1.         The names of the BARDA attendees at the meeting
2.         The title of Dr. Peter Cardinal
3.         Clarification on item 1t that –b(4)----------------------- would be addressed on       a strain-specific basis, and
4.         Clarification on item 1w regarding whether PSC indicated that it would repeat the             container closure integrity validation using 3 lots.
Dr. Post indicated that she would email a response as soon as possible.

Page Last Updated: 09/24/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English